Five cases of dual isolations of different serotypes of avian paramyxoviruses (APMV) from domestic and wild birds are described: one case of mixed infection by APMV-1 and APMV-4 and four cases of infection by APMV-1 and APMV-2 serotypes. The double infection was proven by consecutive isolations of two viruses from allantoic fluid samples derived from single swabs after their respective treatment by antisera against each suspected virus. The finding of double APMV infection in poultry farms appears to be important for epizootiology and pathogenesis of APMV-caused diseases.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0378-1135(97)00147-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Protective efficacy of classical vaccines and vaccination protocols against an exotic Newcastle disease virus genotype VII.2 in Belgian layer and broiler chickens.
Poult Sci
January 2025
Avian Virology and Immunology, Sciensano, Rue Groeselenberg 99, Uccle, Brussels 1180, Belgium.
Vaccination against Newcastle disease (ND) has been routinely implemented in the Belgian professional poultry sector since 1993, using genotype I and II vaccines. Despite this, an outbreak of genotype VII.2 avian paramyx-ovirus 1 (APMV-1) occurred in 2018, with 20 reported cases over the course of 3 months.
View Article and Find Full Text PDFGenomic Diversity and Evolutionary Insights of Avian Paramyxovirus-1 in Avian Populations in Pakistan.
Viruses
September 2024
Virology Department, Animal and Plant Health Agency (APHA), Addlestone KT15 3NB, UK.
Article Synopsis
- Newcastle Disease Virus (NDV), a virulent form of Avian paramyxovirus-1, significantly impacts both wild and domestic birds globally, particularly posing challenges to Pakistan's poultry industry.
- Research over the past 20 years in Pakistan revealed great genetic diversity among NDV strains, necessitating tailored vaccination strategies and ongoing surveillance.
- The study identified 13 APMV-1 isolates across four genotypes, including highly virulent strains, emphasizing the complexity of NDV evolution and the urgent need for coordinated global efforts to manage its effects on avian health.
A multi-species, multi-pathogen avian viral disease outbreak event: Investigating potential for virus transmission at the wild bird - poultry interface.
Emerg Microbes Infect
December 2024
Virology Department, Animal and Plant Health Agency (APHA) Weybridge, Addlestone, UK.
A free-range organic broiler () premises in Staffordshire was infected by high pathogenicity avian influenza virus (HPAIV) H5N8 during the 2020-2021 epizootic in the United Kingdom (UK). Following initial confirmation of the infection in poultry, multiple wild bird species were seen scavenging on chicken carcasses. Detected dead wild birds were subsequently demonstrated to have been infected and succumbed to HPAIV H5N8.
View Article and Find Full Text PDFGenetic Characterization of Avian Paramyxovirus Isolated from Wild Waterfowl in Korea between 2015 and 2021.
Animals (Basel)
March 2024
Department of Avian Diseases, College of Veterinary Medicine and Center for Avian Disease, Jeonbuk National University, Iksan 54596, Republic of Korea.
Article Synopsis
- * Phylogenetic analysis revealed that 10 APMV-1 isolates were linked to Eurasia while 3 were related to viruses from the USA, indicating potential international transmission.
- * The research shows that APMVs are present in wild geese in Korea and provides new evidence for the existence of APMV-1 class I and APMV-13 in this region.
In vivo challenge studies on vaccinated chickens indicate a virus genotype mismatched vaccine still offers significant protection against NDV.
Vaccine
January 2024
Department of Virology, Animal and Plant Health Agency, Woodham Lane, Addlestone, Surrey KT15 3NB, United Kingdom. Electronic address:
Although commercial vaccines against Newcastle Disease have been available for decades, outbreaks still occur in the face of vaccination Further vaccination may accelerate viral evolution resulting in a further reduction in vaccine efficacy. A key question is whether genotype-matched vaccines can confer better protection against contemporary type 1 Avian Paramyxoviruses. To assess this, an in vivo vaccine-challenge study was undertaken to assess protection afforded by 'genotype-matched' and commercial vaccine formulations.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!